Compassionate Use or Expanded Access of Dupilumab | MicrobiomeTrials← Back to trialsNCT04776694
Compassionate Use or Expanded Access of Dupilumab
AVAILABLEEXPANDED_ACCESS
Other microbiome trials you might be interested in
Inflammatory Bowel DiseaseCrohn's DiseaseUlcerative Colitis
Background:
Inflammatory bowel disease (IBD) is a term used to describe disorders that cause long-term inflammation in …
Bethesda, United StatesEst. completion Jun 1, 2036
Type 1 Diabetes (T1D)
Islet transplantation restores glucose tolerance in people living with diabetes characterised by high glycaemic variabil…
Strasbourg, FranceEst. completion Jan 2032
Gastrointestinal Disease Symptoms
The aim of this study is to determine how regular consumption of Synbiotic+, a dietary supplement that contains prebioti…
Fort Collins, United StatesCompleted Aug 1, 2026